THRIVE Trademark

Trademark Overview

On Thursday, January 3, 2019, a trademark application was filed for THRIVE with the United States Patent and Trademark Office. The USPTO has given the THRIVE trademark a serial number of 88978332. The federal status of this trademark filing is REGISTERED as of Tuesday, August 18, 2020. This trademark is owned by Apic Bio, Inc.. The THRIVE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of gene therapy preparations for use in the treatment of autosomal dominant disorders
thrive

General Information

Serial Number88978332
Word MarkTHRIVE
Filing DateThursday, January 3, 2019
Status700 - REGISTERED
Status DateTuesday, August 18, 2020
Registration Number6132202
Registration DateTuesday, August 18, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2019

Trademark Statements

Goods and ServicesDevelopment of gene therapy preparations for use in the treatment of autosomal dominant disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 25, 2019
Primary Code042
First Use Anywhere DateMonday, January 7, 2019
First Use In Commerce DateMonday, January 7, 2019

Trademark Owner History

Party NameApic Bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameApic Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameApic Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, August 18, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, July 15, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 14, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 9, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, June 22, 2020USE AMENDMENT FILED
Thursday, July 9, 2020DIVISIONAL PROCESSING COMPLETE
Monday, June 22, 2020DIVISIONAL REQUEST RECEIVED
Thursday, July 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 22, 2020TEAS REQUEST TO DIVIDE RECEIVED
Monday, June 22, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, December 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 16, 2019ASSIGNED TO LIE
Tuesday, September 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 22, 2019NON-FINAL ACTION E-MAILED
Friday, March 22, 2019NON-FINAL ACTION WRITTEN
Thursday, March 21, 2019ASSIGNED TO EXAMINER
Friday, January 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 7, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

thrive autosomal dominant disorders treatment preparations gene therapy development